• Humacyte’s (HUMA) Statements to Investors Called Into Question in Light of FDA Violations – Hagens Berman | Morningstar

    Источник: Buzz FX / 08 ноя 2024 09:01:30   America/Chicago


    Humacyte’s (HUMA) Statements to Investors Called Into Question in Light of FDA Violations – Hagens Berman SAN FRANCISCO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ: HUMA), a biotechnology company focused on developing acellula
    Read more...
Опубликовать